Welcome to the May 2012 issue of Pharmaceutical Technology Sourcing and Management, your information resource about the pharmaceutical supply chain. In this issue, analysis of the Obama Administration’s blueprint for a bioeconomy. Also, CROs call for regulatory reform to modernize clinical trials. And the latest developments from the bio/pharmaceutical industry relating to corporate social responsibility and sustainability.

Biologics
White House Releases National Bioeconomy Blueprint
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management
The Obama administration details five strategic imperatives to drive bioscience research as a means of economic growth.

Contract Services
CROs Urge for Modernization of Clinical Trials
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management.
CROs seek regulatory reform in the clinical-trial process, including the establishment of a chief innovation officer at FDA.

Outsourcing
Ways to Recover Lost Margins
Gregg Brandyberry, CEO of Wildfire Commerce
Recovery audits and other past practices in procurement can improve the bottom line.

Advertisement:

When Softgels Are a Good First Option: Overcoming Bioavailability Challenges
Event Date: June 12, 2012 at 11:00 AM EDT
Register for this FREE WEBCAST!
Click Here

CSR and Sustainability Forum
Pharmaceutical Technology’s dedicated editorial coverage on the developments in corporate social responsibility (CSR) and sustainability from the bio/pharmaceutical industry, other business sectors, and public and private organizations. This month, we feature an industry roundtable on sustainability in global health, a progress report on GlaxoSmithKline’s sustainability goals, and a roundup of CSR and sustainability news.

The Marriage of Global Health and Sustainability
A roundtable moderated by Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management
Jane Griffiths, PhD and company group chair of Johnson & Johnson’s Janssen for Europe, the Middle East and Africa, and Emma Waters, MD and specialty registrar at the Sustainable Development Unit at the UK government’s National Health Service, discuss the role of sustainability in global health.

GlaxoSmithKline Outlines Sustainability Objectives
The company provides progress made in 2011 and future environmental objectives.

CSR and Sustainability in the News
A roundup of developments in corporate social responsibility and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.